To begin, Mr. Chair, I hope that everybody around the table understands that the COVAX facility does have two arms, and it was deliberately set up to allow developing countries to procure a limited number of doses.
The doses that we are procuring from COVAX are part of the way in which this was established. At the same time, we are basically providing subsidies to ensure that there is manufacturing that is able to occur for doses to go to the developing world—